Results 71 to 80 of about 63,983 (304)

The ubiquitin ligase RNF115 is required for the clearance of damaged lysosomes

open access: yesFEBS Letters, EarlyView.
Upon lysosomal rupture, an E3 ubiquitin ligase RNF115 translocates from the cytosol to the damaged lysosomal membrane. Moreover, RNF115 depletion impairs the clearance of damaged lysosomes, identifying it as a key regulator of lysosomal quality control.
Sae Nakanaga   +3 more
wiley   +1 more source

Performance Measures to Assess Resiliency and Efficiency of Transit Systems [PDF]

open access: yes, 2017
Transit agencies are interested in assessing the short-, mid-, and long-term performance of infrastructure with the objective of enhancing resiliency and efficiency.
Bartin, Bekir   +9 more
core   +1 more source

pH‐mediated activation of the lysosomal arginine sensor SLC38A9

open access: yesFEBS Letters, EarlyView.
Cells monitor nutrient levels via the lysosomal transporter SLC38A9 to activate the mechanistic target of rapamycin complex 1 (mTORC1). This study reveals that SLC38A9 function is regulated by pH. We identified histidine 544 as a critical pH sensor that undergoes conformational changes to control amino acid efflux from lysosomes; therefore, it ...
Xuelang Mu, Ampon Sae Her, Tamir Gonen
wiley   +1 more source

Fixed-Route vs. Demand-Responsive Transport Feeder Services: An Exploratory Study Using an Agent-Based Model

open access: yesJournal of Advanced Transportation, 2022
Feeder transport services are fundamental as first and last-mile connectors of mass rapid transit (MRT). They are especially beneficial in low-demand areas where private transport is usually the main transport mode.
Giovanni Calabrò   +5 more
doaj   +1 more source

Impact assessment of autonomous DRT systems [PDF]

open access: yes, 2019
The market entrance of shared autonomous vehicles (SAV) may have disruptive effects on current transport systems and may lead to their total transformation.
Bischoff, Joschka   +2 more
core   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Information Management of Demand-Responsive Mobility Service Based on Autonomous Vehicles [PDF]

open access: yes, 2017
The autonomous road vehicle (AV) technology implies significant alteration of urban mobility services. The identified transit modes based on AVs are the individual cars, the demand-responsive public transportation with small or medium sized pods ...
Csiszár, Csaba   +2 more
core   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

The Role of Demand-Responsive Transport Systems in Sustainable Urban Mobility: A Systematic Literature Review and Stakeholder Analysis

open access: yesEngineering Proceedings
On-demand transportation, such as demand-responsive public transit (DRT), is gaining prominence as a mobility service tailored to passengers’ needs, offering flexibility in routes, pick-up/drop-off locations, and timing. This study aims to delve into the
László Buics   +2 more
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy